C6-NBD Ceramide
Manufacturer: Sigma Aldrich
CAS Number: 94885-02-6
Synonym(S): N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine:methanol (8:2)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810209X-1-MG | In Stock | ₹ 55,355.85 |
810209X - 1 MG
In Stock
Quantity
1
Base Price: ₹ 55,355.85
GST (18%): ₹ 9,964.053
Total Price: ₹ 65,319.903
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (810209X-1mg)
manufacturer/tradename
Avanti Polar Lipids 810209X
concentration
1 mg/mL (810209X-1mg)
shipped in
dry ice
storage temp.
−20°C
InChI
1S/C30H49N5O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-27(37)25(23-36)32-28(38)19-16-14-17-22-31-24-20-21-26(35(39)40)30-29(24)33-41-34-30/h15,18,20-21,25,27,31,36-37H,2-14,16-17,19,22-23H2,1H3,(H,32,38)/b18-15+/t25-,27+/m0/s1
InChI key
HZIRBXILQRLFIK-VPZZKNKNSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Cayman Chemical C6 NBD Ceramide (d18:1/6:0), 94885-02-6, 1 mg | Cayman Chemical | ₹ 9,642.61 | |
 | C6 NBD Ceramide | ChemScene | ₹ 33,368.40 | |
 | 94885-02-6 | Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]- | A2B Chem | ₹ 7,614.84 - ₹ 52,876.08 |
Related Products
Description
- General description: C6-NBD ceramide is a fluorescent labelled compound, known to be useful for the detection of enzymatic action. C6-NBD ceramide is preferred over radioactive compounds.[1]
- Application: C6-NBD Ceramide is suitable as a substrate for sphingomyelin synthase activity assay.[2]
- Biochem/physiol Actions: Sphingolipid metabolism yields ceramide as one of the products. The family of ceramide synthases catalyses its synthesis. The ceramides differ in its acyl chain length. Ceramides possess a wide range of functions, associated with apoptosis, cancer inhibition and chemotherapy. Its action is also related to neurodegenerative diseases.[3]
- Packaging: 5 mL Amber Glass Screw Cap Vial (810209X-1mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P311 - P308 + P311
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 1 - STOT SE 3
Target Organs
Central nervous system, Eyes,Central nervous system, Liver,Kidney
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810209X-1mg)
manufacturer/tradename: Avanti Polar Lipids 810209X
concentration: 1 mg/mL (810209X-1mg)
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C30H49N5O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-27(37)25(23-36)32-28(38)19-16-14-17-22-31-24-20-21-26(35(39)40)30-29(24)33-41-34-30/h15,18,20-21,25,27,31,36-37H,2-14,16-17,19,22-23H2,1H3,(H,32,38)/b18-15+/t25-,27+/m0/s1
InChI key: HZIRBXILQRLFIK-VPZZKNKNSA-N
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 100 μg (with stopper and crimp cap (810210P-100ug))
manufacturer/tradename: Avanti Polar Lipids 810210P
concentration: __
shipped in: dry ice
storage temp.: −20°C
InChI: __
InChI key: __
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810211C-1mg)
manufacturer/tradename: Avanti Polar Lipids 810211C
concentration: 1 mg/mL (810211C-1mg)
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C36H61N5O6/c1-2-3-4-5-6-7-8-9-10-12-15-18-21-24-33(43)31(29-42)38-34(44)25-22-19-16-13-11-14-17-20-23-28-37-30-26-27-32(41(45)46)36-35(30)39-47-40-36/h21,24,26-27,31,33,37,42-43H,2-20,22-23,25,28-29H2,1H3,(H,38,44)/b24-21+/t31-,33+/m0/s1
InChI key: SNOJCYCOPNIGIK-ULETYAGTSA-N